Surprise in the community causes the... sudden limit up of his stock Athens Medical School, by triggering scenarios that - already - are in stock exchange (but not only) offices.
With «Good morning» From 1,78 to 2,19 euros - new high - and earlier to 2,07 euros (17,96%) and even with increased transactions.
The scenarios heard speak of an interest in a foreign fund and also of an upcoming public proposal. In contact with Euro2day.gr, It has been stated that fame is not valid and that it will answer officially on the matter in the capital market authorities.
Rumors
Given the «tight» Free float Apostolopoulos side has 50% and 36% of the German group Asklepios- the question is «where» There is such increased turnover, especially today.
It should be noted that the regular general meeting of shareholders; with brokers paying particular attention because of what has been ahead of them in recent years.
Given the percentage raised by the two shareholders, rumours want the administration to intend to announce Public proposal (for «exit» from Euronext Athens, taking into account that it has not complied with the condition of free diaspora. Other sources also mention interest foreign fund (with indirect presence in the wider insurance sector).
What's the situation? After 40 years at the steering wheel of the Athens Medical Group, it is time to leave for George Apostolopoulos.
Initiator, founder and one of the leading actors in the industry, a lifelong president of the Board became in 2025 an honorary (with executive powers). The management of the group now decides to honor him and that is why the remuneration policy is provided for, as The Chameleon column also wrote, compensation of three monthly salaries for each year for Presidents of the Board, with a term beyond 40 years in the event of their retirement.
The report explicitly mentions an indication of recognition and appreciation of the overall contribution and the continuous footprint left in the company's course, through the extremely long and decisive contribution from the position of president and the substantial contribution to strategic development, stability and strengthening corporate value. This will come to the vote and if approved, the fund will open for payment of 3 (monthly payments) X 40 years of service = 120 months' salary.
According to the accounting statements, the founder and major shareholder will have received a total of EUR 22 plus million.
Interesting development, it remains to be seen what the attitude of the Germans (of Asklepios), minority shareholders and the creditors of the quoted one will be.
The announcement to the Stock Exchange
The company also proceeded to an official disclaimer with its posting on the Stock Exchange.
In particular, the company named «MEDICAL ATHENS TRADE ANNOUNCEMENT COMPANY» (hereinafter referred to as «Company»), informs the investment audience of the following:
With regard to the current publications that appeared in the electronic press and refer to an alleged agreement to acquire the Company from a foreign fund and/or upcoming public proposal to leave Euronext Athens, the Company, following information received from its main shareholders, states that These publications are untrue and have no basis whatsoever.
The Company remains committed to the transparent, timely and equal information of the investment audience and whenever there are business developments that require disclosure in accordance with the current legislative framework, it makes all necessary disclosure of privileged information, always complying with capital market law.
This information shall be made in accordance with Article 17 of Regulation (EU) No 182/2011. 596/2014 (MAR) and following a relevant question from the Securities and Exchange Commission.
